Gómez-Guerrero C, Duque N, Egido J
Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain.
J Am Soc Nephrol. 1998 Apr;9(4):568-76. doi: 10.1681/ASN.V94568.
Asialoglycoprotein receptor (ASGP-R), a hepatic lectin involved in the clearance of galactose-terminal glycoproteins, is also present in extrahepatic tissues, but its expression in renal cells is not well established. This study examines the presence of ASGP-R in cultured mesangial cells (MC), key cells involved in the removal of macromolecules deposited in the glomerulus. The binding of asialo-orosomucoid (ASOR) to rat MC was saturable and galactose-specific. In addition, MC internalized and degraded ASOR in a Ca(2+)-dependent manner. Parallel studies were performed in a homologous system (human MC), obtaining similar binding curve and competition with unlabeled ASOR and carbohydrates. The purified receptor from rat MC consisted of two proteins (41 and 55 kD) with similar size to the hepatic receptor. Both subunits were detected by mRNA expression analysis (ratio 2:1). Because the hepatic receptor presents avidity for the carbohydrates of IgA1, a protein deposited in the glomerulus of patients with IgA nephropathy, the interaction of IgA1 with the mesangial ASGP-R was explored. As for the interaction with ASOR, catabolism of IgA1 by rat and human MC was Ca(2+)-dependent and was reduced with galactose. In addition, the interaction of ASOR with rat MC was partially inhibited by incubation with IgA1 and its desialylated form, but not by IgA2, as demonstrated in binding experiments and in receptor purification. It is concluded that MC possess ASGP-R specific for galactose residues of several glycoproteins, including IgA1. These data could be important for a better understanding of the pathogenesis of IgA nephropathy.
去唾液酸糖蛋白受体(ASGP-R)是一种参与清除半乳糖末端糖蛋白的肝凝集素,也存在于肝外组织中,但其在肾细胞中的表达尚未完全明确。本研究检测了培养的系膜细胞(MC)中ASGP-R的存在,MC是参与清除沉积在肾小球中的大分子的关键细胞。去唾液酸血清类黏蛋白(ASOR)与大鼠MC的结合具有饱和性且对半乳糖具有特异性。此外,MC以Ca(2+)依赖的方式内化并降解ASOR。在同源系统(人MC)中进行了平行研究,获得了相似的结合曲线以及与未标记的ASOR和碳水化合物的竞争结果。从大鼠MC中纯化的受体由两种蛋白质(41和55 kD)组成,其大小与肝受体相似。通过mRNA表达分析检测到了这两个亚基(比例为2:1)。由于肝受体对IgA1的碳水化合物具有亲和力,IgA1是IgA肾病患者肾小球中沉积的一种蛋白质,因此研究了IgA1与系膜ASGP-R的相互作用。至于与ASOR的相互作用,大鼠和人MC对IgA1的分解代谢是Ca(2+)依赖的,并且在有半乳糖的情况下会减少。此外,如结合实验和受体纯化实验所示,与IgA1及其去唾液酸化形式孵育可部分抑制ASOR与大鼠MC的相互作用,但IgA2则无此作用。结论是MC拥有对包括IgA1在内的几种糖蛋白的半乳糖残基具有特异性的ASGP-R。这些数据对于更好地理解IgA肾病的发病机制可能很重要。